Riccardo Soffietti is a Professor in Neurology and Neuro-Oncology, Dept. Neuroscience ‘Rita Levi Montalcini’, University of Turin, Italy; Head, Dept. Neuro-Oncology, City of Health and Science University Hospital of Turin, Italy. Longstanding experience in clinical neuro-oncology. Specific research experience in designing, coordinating, and conducting clinico-translational trials of phase II and III in glioblastomas and lower grade gliomas, lymphomas, ependymomas, medulloblastomas, brain metastasis, and neoplastic meningitis with new drugs (including targeted agents, such as EGFR inhibitors, mTOR inhibitors, anti-VEGF compounds). Specific research experience in monitoring treatment effects with advanced neuroimaging techniques (MRS spectroscopy, PET with FDG, and amino acids). Specific research experience in studies on prognostic and predictive factors (clinical, radiological, pathological, and molecular) in gliomas and ependymomas. Member of the Editorial Board: Neuro-Oncology, Neuro-Oncology Practice, Anticancer Drugs, Journal of Neurology, Current Cancer Therapy Reviews, CNS Oncology and Neurological Sciences. Executive Editor, Neuro-Oncology, Oxford University Press, (IF: 10.091).